TY - JOUR
T1 - Contemporary Profile of Seizures in Neonates
T2 - A Prospective Cohort Study
AU - Neonatal Seizure Registry Study Group
AU - Glass, Hannah C.
AU - Shellhaas, Renée A.
AU - Wusthoff, Courtney J.
AU - Chang, Taeun
AU - Abend, Nicholas S.
AU - Chu, Catherine J.
AU - Cilio, M. Roberta
AU - Glidden, David V.
AU - Bonifacio, Sonia L.
AU - Massey, Shavonne
AU - Tsuchida, Tammy N.
AU - Silverstein, Faye S.
AU - Soul, Janet S.
AU - Bergin, Ann Marie
AU - Dlugos, Dennis
AU - Ferriero, Donna M.
AU - Staley, Kevin
N1 - Funding Information:
Supported by the Pediatric Epilepsy Research Foundation (Multi-center Neonatal Seizure Registry/ A120625 ). H.G. is supported by the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (K23NS066137) and the Neonatal Brain Research Institute at University of California, San Francisco. J.S. is supported by Boston Children's Hospital Intellectual and Developmental Disabilities Research Center (P30 HD18655). REDCap (Research Electronic Data Capture) tools is supported by University of California, San Francisco. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.
Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2016/7/1
Y1 - 2016/7/1
N2 - Objective To determine the contemporary etiology, burden, and short-term outcomes of seizures in neonates monitored with continuous video-electroencephalogram (cEEG). Study design We prospectively collected data from 426 consecutive neonates (56% male, 88% term) ≤44 weeks' postmenstrual age with clinically suspected seizures and/or electrographic seizures. Subjects were assessed between January 2013 and April 2015 at 7 US tertiary care pediatric centers following the guidelines of the American Clinical Neurophysiology Society for cEEG for at-risk neonates. Seizure etiology, burden, management, and outcome were determined by chart review by the use of a case report form designed at study onset. Results The most common seizure etiologies were hypoxic-ischemic encephalopathy (38%), ischemic stroke (18%), and intracranial hemorrhage (11%). Seizure burden was high, with 59% having ≥7 electrographic seizures and 16% having status epilepticus; 52% received ≥2 antiseizure medications. During the neonatal admission, 17% died; 49% of survivors had abnormal neurologic examination at hospital discharge. In an adjusted analysis, high seizure burden was a significant risk factor for mortality, length of hospital stay, and abnormal neurological examination at discharge. Conclusions In this large contemporary profile of consecutively enrolled newborns with seizures treated at centers that use cEEG per the guidelines of the American Clinical Neurophysiology Society, about one-half had high seizure burden, received ≥2 antiseizure medications, and/or died or had abnormal examination at discharge. Greater seizure burden was associated with increased morbidity and mortality. These findings underscore the importance of accurate determination of neonatal seizure frequency and etiology and a potential for improved outcome if seizure burden is reduced.
AB - Objective To determine the contemporary etiology, burden, and short-term outcomes of seizures in neonates monitored with continuous video-electroencephalogram (cEEG). Study design We prospectively collected data from 426 consecutive neonates (56% male, 88% term) ≤44 weeks' postmenstrual age with clinically suspected seizures and/or electrographic seizures. Subjects were assessed between January 2013 and April 2015 at 7 US tertiary care pediatric centers following the guidelines of the American Clinical Neurophysiology Society for cEEG for at-risk neonates. Seizure etiology, burden, management, and outcome were determined by chart review by the use of a case report form designed at study onset. Results The most common seizure etiologies were hypoxic-ischemic encephalopathy (38%), ischemic stroke (18%), and intracranial hemorrhage (11%). Seizure burden was high, with 59% having ≥7 electrographic seizures and 16% having status epilepticus; 52% received ≥2 antiseizure medications. During the neonatal admission, 17% died; 49% of survivors had abnormal neurologic examination at hospital discharge. In an adjusted analysis, high seizure burden was a significant risk factor for mortality, length of hospital stay, and abnormal neurological examination at discharge. Conclusions In this large contemporary profile of consecutively enrolled newborns with seizures treated at centers that use cEEG per the guidelines of the American Clinical Neurophysiology Society, about one-half had high seizure burden, received ≥2 antiseizure medications, and/or died or had abnormal examination at discharge. Greater seizure burden was associated with increased morbidity and mortality. These findings underscore the importance of accurate determination of neonatal seizure frequency and etiology and a potential for improved outcome if seizure burden is reduced.
KW - EEG
KW - critical care
KW - electroencephalogram
KW - epilepsy
KW - hypoxic-ischemic encephalopathy
KW - infant
KW - neonatal encephalopathy
KW - neonatal seizures
KW - neurocritical care
UR - http://www.scopus.com/inward/record.url?scp=84963877880&partnerID=8YFLogxK
U2 - 10.1016/j.jpeds.2016.03.035
DO - 10.1016/j.jpeds.2016.03.035
M3 - Article
C2 - 27106855
AN - SCOPUS:84963877880
SN - 0022-3476
VL - 174
SP - 98-103.e1
JO - Journal of Pediatrics
JF - Journal of Pediatrics
ER -